A single 30 mL vial of bacteriostatic water may reconstitute three to five peptide vials over the course of a cycle
The safety profile was consistent with GLP-1 receptor agonists, with gastrointestinal events including nausea, vomiting, diarrhea, constipation, or abdominal pain, being most common (affecting 79.6% in the cagrilintidesemaglutide group and 39.9% in the placebo group) but mainly transient and mild to moderate in severity
Comprehensive BPC-157 Dosage Protocols Beginner Protocol (Weeks 1-2) Daily Dose : 200-250 mcg subcutaneous injection Timing : Morning and evening (split dosing) Frequency : Twice daily (12 hours apart) Assessment Period : Monitor healing response for 14 days Starting with 200-250 mcg allows assessment of individual response while providing therapeutic benefits
The most common side effect is minor, temporary redness or discomfort at the injection site
That said, GI issues have many causes and BPC-157 is not a substitute for a proper diagnosis
